338P A new clinically applicable immune-metabolic signature (IMMETCOLS) reveals metabolic singularities in consensus molecular subtypes (CMS) in colorectal cancer

Autor: Madurga, S., Foguet, C., Oliveres, H., Mas, F., Maurel, J., Cascante, M.
Zdroj: In Annals of Oncology September 2022 33 Supplement 7:S691-S691
Databáze: ScienceDirect